# Addition of Dexmedetomidine to Ropivacaine in Bilateral Erector Spinae Plane Block in Patients Undergoing Coronary Artery Bypass Surgery

> **NCT06981949** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Lebanese American University** · enrollment: 110 (estimated)

## Conditions studied

- Pain
- Pain Management Following Cardiopulmonary Bypass Surgery
- Erector Spinae Plane Block

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT06981949
- **Lead sponsor:** Lebanese American University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-15
- **Primary completion:** 2026-05-15
- **Final completion:** 2026-05-16
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06981949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06981949, "Addition of Dexmedetomidine to Ropivacaine in Bilateral Erector Spinae Plane Block in Patients Undergoing Coronary Artery Bypass Surgery". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06981949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*